| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
ADARx Pharmaceuticals, Inc.
13G/A
Amendment 1
ADRX · 00654F105
|
9.6% |
11/16/2026
Event 9/30/2026
|
|||
| Zhen Li | 9.6% | ||||
| Zhiqing Zhou | 5.5% | ||||
| Zhen Li and Zhiqing Zhou, as Co-Trustees of the Titanium Boulder Irrevocable Trust dated July 11, 2020 | 5.5% | ||||
|
ADARx Pharmaceuticals, Inc.
13G
ADRX · 00654F105
|
9.7% |
11/13/2026
Event 9/30/2026
|
|||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.